COVID-19 Is Causing Health Spending To Go Down December 2, 2020 Perspective New analysis from Drew Altman in his latest Axios column on the impact of the coronavirus pandemic on national health spending.
The Exit Polls Show The Need To Confront COVID-19 Denial in Red America November 17, 2020 Perspective Drew Altman analyzes the exit polls in his latest Axios column. While Biden voters see COVID-19 as a top priority, Trump supporters are still largely pandemic deniers, echoing the President.
A Year of Crisis: How COVID-19 Upended the Election’s Focus on Health Care Policy—Or Did It? October 23, 2020 Perspective In this post, Ashley Kirzinger and Mollyann Brodie examine how the COVID-19 pandemic and other crises shook up the mix of issues voters care about without changing the 2020 presidential race’s core dynamic as a referendum on President Trump’s first term in office.
Want to protect people with preexisting conditions? You need the full Affordable Care Act. October 22, 2020 Perspective In this perspective published by the Washington Post, KFF Executive Vice President for Health Policy Larry Levitt explains why the popular Affordable Care Act provisions that ensure people with pre-existing conditions can access affordable health insurance can’t easily be preserved if other related provisions are overturned.
Joe Biden’s Big Lead on Health Care Issues October 21, 2020 Perspective In an Axios column, Drew Altman discusses how this election year health isn’t a single issue — but several — and Joe Biden has the edge over President Trump on all of them, even as opposition to the ACA remains popular with Trump’s base.
Black Americans Are More Skeptical of a Coronavirus Vaccine October 14, 2020 Perspective Drew Altman discusses how systemic racism has led to striking levels of reluctance to get a COVID-19 vaccine among Black Americans, including those at highest risk, and the challenge it presents for ending the pandemic.
Drugs Aren’t the Reason the U.S. Spends So Much on Health Care September 30, 2020 Perspective Drew Altman’s column in Axios: the U.S. now spends twice per capita what other wealthy countries do on health care. But while drug costs get all the time in public debate, it’s hospital and outpatient spending that mostly explains the difference. And that will be impossible to take on without real pain and political risk, he says.
What Will Candidates Say About Medicare This Election? September 22, 2020 Perspective In this article for the American Society of Aging’s Generations Today, KFF Senior Vice President Tricia Neuman examines what President Trump and former Vice President Joe Biden are saying about key issues for Medicare beneficiaries, including drug prices and affordability, as well as what they aren’t saying about Medicare’s financing.
Biden vs Trump on Health With Swing Voters September 17, 2020 Perspective Drawing on newly released KFF/Cook Political Report polling in key Sun Belt states, Drew Altman discusses how the 2020 election is more about President Trump but issues do matter. He says that swing voters in Florida, Arizona and North Carolina prefer Joe Biden over President Trump on more issues including health care and the coronavirus, but President Trump has the edge on their top issue, the economy.
Drew Altman: Understanding the US Failure on Coronavirus September 14, 2020 Perspective For The BMJ, Drew Altman discusses two fundamental policy decisions made by the Trump administration that set the U.S. on the controversial and highly criticized course it has taken on COVID-19.
